https://www.selleckchem.com/pr....oducts/wortmannin.ht
Biomarker normalization and endoscopic remission are superior to clinical remission in achieving improved long-term clinical outcomes in patients with inflammatory bowel diseases. To study whether higher maintenance adalimumab levels are associated with clinical remission, biomarker normalization, and endoscopic remission. Data were collected retrospectively from the patients' medical records. We defined clinical remission as a Harvey Bradshaw Index ≤5 or a partial Mayo score ≤2 for Crohn's disease (CD) and ulcerative colitis (UC), r
Like
Comment
Share
